| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +0.00% | -11.23% | -0.53% | -10.71% | -10.71% | — |
| 14d | 2 | +0.00% | -10.92% | +0.54% | -11.46% | -11.46% | — |
| 30d | 2 | +0.00% | -10.71% | +2.80% | -13.51% | -13.51% | — |
| 60d | 2 | +50.00% | -15.27% | +3.97% | -19.25% | -19.25% | — |
| 90d | 2 | +0.00% | -34.64% | +3.24% | -37.88% | -37.88% | — |
| 180d | 2 | +50.00% | -6.38% | +11.98% | -18.36% | -18.36% | — |
| 1y | 2 | +50.00% | +11.35% | +25.84% | -14.49% | -14.49% | — |
| 2y | 2 | +50.00% | -30.28% | +49.24% | -79.52% | -79.52% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| AYTU AYTU BIOPHARMA, INC | PURCHASEGRANT Stock grant | 12,500 | — | — | 36,102 | Oct 3, 2025 | Oct 7, 2025 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASE Chief Commercial Officer | 209 | — | — | 23,602 | Mar 31, 2025 | Mar 31, 2025 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | SALE Chief Commercial Officer | 209 | — | — | 0 | Mar 31, 2025 | Mar 31, 2025 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | SALE Chief Commercial Officer | 208 | — | — | 209 | Dec 31, 2024 | Jan 2, 2025 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASE Chief Commercial Officer | 208 | — | — | 23,393 | Dec 31, 2024 | Jan 2, 2025 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASEGRANT Stock grant | 7,000 | — | — | 7,000 | Nov 6, 2024 | Nov 8, 2024 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | SALE Chief Commercial Officer | 209 | — | — | 417 | Sep 30, 2024 | Oct 1, 2024 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASE Chief Commercial Officer | 209 | — | — | 23,185 | Sep 30, 2024 | Oct 1, 2024 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | SALE Chief Commercial Officer | 208 | — | — | 626 | Jun 30, 2024 | Jul 1, 2024 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASE Chief Commercial Officer | 208 | — | — | 22,976 | Jun 30, 2024 | Jul 1, 2024 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASE Chief Commercial Officer | 208 | — | — | 22,768 | Mar 31, 2024 | Apr 1, 2024 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | SALE Chief Commercial Officer | 208 | — | — | 834 | Mar 31, 2024 | Apr 1, 2024 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | SALE Chief Commercial Officer | 209 | — | — | 1,042 | Dec 31, 2023 | Jan 2, 2024 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASE Chief Commercial Officer | 209 | — | — | 22,560 | Dec 31, 2023 | Jan 2, 2024 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASE Chief Commercial Officer | 208 | — | — | 22,351 | Sep 30, 2023 | Sep 30, 2022 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | SALE Chief Commercial Officer | 208 | — | — | 1,251 | Sep 30, 2023 | Sep 30, 2022 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASEGRANT Stock grant | 7,000 | — | — | 7,000 | Aug 11, 2023 | Aug 15, 2023 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASE Chief Commerical Officer | 12,000 | $1.87 | $22.4K | 21,935 | Jun 16, 2023 | Jun 19, 2023 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASE Chief Commerical Officer | 833 | — | — | 9,935 | Apr 25, 2023 | Jun 19, 2023 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | SALE Chief Commerical Officer | 833 | — | — | 1,667 | Apr 25, 2023 | Jun 19, 2023 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASE Chief Commercial Officer | 100,000 | $0.24 | $24.5K | 182,056 | Dec 19, 2022 | Dec 19, 2022 ↗ | View → |